Detalhe da pesquisa
1.
SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir.
J Infect Dis
; 2024 Apr 24.
Artigo
Inglês
| MEDLINE | ID: mdl-38657001
2.
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.
Clin Infect Dis
; 2024 Feb 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38376212
3.
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19.
Ann Intern Med
; 175(10): 1401-1410, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36037469
4.
SARS-CoV-2 seroprevalence in vaccine-naïve participants from the Democratic Republic of Congo, Guinea, Liberia, and Mali.
Int J Infect Dis
; 142: 106985, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38417612
5.
Front-Line Emergency Department Clinician Acceptability and Use of a Prototype Real-Time Cloud-Based Influenza Surveillance System.
Front Public Health
; 9: 740258, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34805066
6.
A Continuous, Long-Term Plasmodium vivax In Vitro Blood-Stage Culture: What Are We Missing?
Trends Parasitol
; 33(12): 921-924, 2017 12.
Artigo
Inglês
| MEDLINE | ID: mdl-28780020